[HTML][HTML] Phosphorylated tau in Alzheimer's disease and other tauopathies

P Rawat, U Sehar, J Bisht, A Selman… - International Journal of …, 2022 - mdpi.com
Alzheimer's disease (AD) is the leading cause of dementia in elderly people. Amyloid beta
(Aβ) deposits and neurofibrillary tangles are the major pathological features in an …

[HTML][HTML] Dysfunction of mitochondria in Alzheimer's disease: ANT and VDAC interact with toxic proteins and aid to determine the fate of brain cells

A Atlante, D Valenti, V Latina, G Amadoro - International Journal of …, 2022 - mdpi.com
Alzheimer's disease (AD), certainly the most widespread proteinopathy, has as classical
neuropathological hallmarks, two groups of protein aggregates: senile plaques and …

[HTML][HTML] Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease

PJ Visser, LM Reus, J Gobom, I Jansen, E Dicks… - Molecular …, 2022 - Springer
Background Increased total tau (t-tau) in cerebrospinal fluid (CSF) is a key characteristic of
Alzheimer's disease (AD) and is considered to result from neurodegeneration. T-tau levels …

[HTML][HTML] Bassoon contributes to tau-seed propagation and neurotoxicity

P Martinez, H Patel, Y You, N Jury, A Perkins… - Nature …, 2022 - nature.com
Tau aggregation is a defining histopathological feature of Alzheimer's disease and other
tauopathies. However, the cellular mechanisms involved in tau propagation remain unclear …

Tau Oligomer–Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease

RN Taddei, R Perbet, AM de Gerando… - JAMA …, 2023 - jamanetwork.com
Importance Factors associated with synapse loss beyond amyloid-β plaques and
neurofibrillary tangles may more closely correlate with the emergence of cognitive deficits in …

Age-related and amyloid-beta-independent tau deposition and its downstream effects

A Wuestefeld, A Pichet Binette, D Berron, N Spotorno… - Brain, 2023 - academic.oup.com
Amyloid-β (Aβ) is hypothesized to facilitate the spread of tau pathology beyond the medial
temporal lobe. However, there is evidence that, independently of Aβ, age-related tau …

[HTML][HTML] Connecting the dots between hypercholesterolemia and Alzheimer's disease: a potential mechanism based on 27-hydroxycholesterol

M Wu, Y Zhai, X Liang, W Chen, R Lin, L Ma… - Frontiers in …, 2022 - frontiersin.org
Alzheimer's disease (AD), the most common cause of dementia, is a complex and
multifactorial disease involving genetic and environmental factors, with …

Friend or foe: role of pathological tau in neuronal death

M Wu, Z Chen, M Jiang, B Bao, D Li, X Yin… - Molecular …, 2023 - nature.com
Neuronal death is one of the most common pathological hallmarks of diverse neurological
diseases, which manifest varying degrees of cognitive or motor dysfunction. Neuronal death …

[HTML][HTML] Empagliflozin Induced Ketosis, upregulated IGF-1/Insulin receptors and the Canonical Insulin Signaling Pathway in neurons, and decreased the excitatory …

KI Avgerinos, RJ Mullins, M Vreones, M Mustapic… - Cells, 2022 - mdpi.com
Sodium-glucose cotransporter-2 inhibitors (SGLT2is), such as empagliflozin, lower blood
glucose in type 2 diabetes mellitus and improve cardiorenal outcomes regardless of …

[HTML][HTML] Alzheimer's disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression

S Meftah, J Gan - Frontiers in Synaptic Neuroscience, 2023 - frontiersin.org
The synapse has consistently been considered a vulnerable and critical target within
Alzheimer's disease, and synapse loss is, to date, one of the main biological correlates of …